Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Le Duff, F., Bouaziz, J. D., Fontas, E., Ticchioni, M., Viguier, M., Dereure, O., … Passeron, T. (2021). Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations. Journal of Investigative Dermatology, 141(4), 933-936.e6. https://doi.org/10.1016/j.jid.2020.08.015